Tailoring iPSC Therapies for Autoimmune Diseases to Address Unmet Patient Needs
Time: 9:30 am
day: Conference Day Two
Details:
- Delving into the potential of using patient-derived iPSCs to create targeted cell therapies for specific autoimmune diseases
- Regulating the immune system and achieving disease remission in autoimmune conditions
- Developing rigorous preclinical models that accurately reflect the human immune response to assess the safety and effectiveness of iPSC therapies for autoimmune diseases
